SCHEMBL2092609

SCHEMBL2092609

CCCCc1ccc(OCO)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.57
▸ LMNA P02545 3/20 0.57
▸ CYP3A4 P08684 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ USP2 O75604 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ CASP1 P29466 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ SLCO1B3 Q9NPD5 1/20 0.57
▸ SLCO1B1 Q9Y6L6 1/20 0.57
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ HSD17B10 Q99714 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ THRB P10828 1/20 0.47
▸ LTA4H P09960 1/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ ESR1 P03372 2/20 0.47
▸ ADRA2A P08913 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312372 0.92 ALDH1A1 (0.67) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL14631088 0.88 ALDH1A1 (0.53) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL16933991 0.85 LMNA (0.62) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL1847544 0.85 ALDH1A1 (0.71) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL8986268 0.83 NQO1 (0.61) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL2091770 0.83 LTA4H (0.61) CYP3A4CA1CA2LTA4HTP53
SCHEMBL3027395 0.82 ALDH1A1 (0.69) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL23898458 0.82 LTA4H (0.58) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL26119938 0.82 MEN1 (0.68) ALDH1A1LMNACYP3A4MEN1USP2
SCHEMBL25548716 0.82 NQO1 (0.58) ALDH1A1LMNACYP3A4MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112812358-B Reclaimed rubber 财团法人工业技术研究院 2023-05-09 — — CN claimed
CN-112075550-A Full-effect astaxanthin water adjusting agent for aquaculture and preparation method thereof 中国科学院烟台海岸带研究所 2020-12-15 — — CN claimed
CN-120065551-A Contact lens and contact lens product 星欧光学股份有限公司 2025-05-30 — — CN disclosed
US-20250170295-A1 CONTACT LENS AND CONTACT LENS PRODUCT LARGAN MEDICAL CO., LTD. (TW) 2025-05-29 — — US disclosed
CN-119040051-B Lubricating grease prepared from metal salt and preparation method thereof 纳拓新材料(江苏)有限公司 2025-04-29 — — CN disclosed
CN-119816518-A Anti-LILRB 2 antibodies and uses thereof 科望(苏州)生物医药科技有限公司 2025-04-11 — — CN disclosed
CN-119654344-A Anti-SIGLEC 15 antibodies and uses thereof 科望(苏州)生物医药科技有限公司 2025-03-18 — — CN disclosed
CN-119040051-A Lubricating grease prepared from metal salt and preparation method thereof 纳拓新材料(江苏)有限公司 2024-11-29 — — CN disclosed
CN-113163783-B Grease composition 花王株式会社 2024-05-28 — — CN disclosed
CN-117883429-A Composition and ophthalmic product 星欧光学股份有限公司 2024-04-16 — — CN disclosed
CN-116133671-A Recombinant vaccinia virus 辉瑞公司 2023-05-16 — — CN disclosed
CN-112812358-B Reclaimed rubber 财团法人工业技术研究院 2023-05-09 — — CN disclosed
CN-113631178-A Antiviral lectins and uses thereof 台湾地区“中央研究院” 2021-11-09 — — CN disclosed
CN-112888460-A Wild-type and mutant-type degradation agents for LRKK2 达纳-法伯癌症研究所有限公司 2021-06-01 — — CN disclosed
CN-105748537-B Application of undaria pinnatifida ethanol extract in preparation of composition for treating or preventing influenza A virus infection 吴彰哲 2021-04-09 — — CN disclosed
CN-112075550-A Full-effect astaxanthin water adjusting agent for aquaculture and preparation method thereof 中国科学院烟台海岸带研究所 2020-12-15 — — CN disclosed
CN-111936444-A Interlayer film for laminated glass, and method for mounting laminated glass 积水化学工业株式会社 2020-11-13 — — CN disclosed
US-8163753-B2 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-04-24 — — US disclosed
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 — — EP disclosed
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis OTSUKA PHAMACEUTICAL CO., LTD. (JP) 2008-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119478-A1 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis NR2C2, NR0B2, NR4A2 ALDH1A1 412/4885LMNA 4594/4885CYP3A4 1734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback